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Localized nasal, conjunctival and corneal amyloidosis was diagnosed in a 15-year-old pony with nasal and conjunctival
masses and severe dyspnoea. Multiple swellings had been evident in the nostrils for at least two years and had
gradually increased in size before presentation due to dyspnoea and exercise intolerance. Surgical debulking of
the masses was performed and histological examination revealed large amounts of extracellular, hyaline, eosinophilic,
Congo red positive material in the lamina propria of the nasal mucosa. A tentative diagnosis of localized nasal
amyloidosis was made. The treatment relieved the clinical signs, however, the nasal masses recurred and bilateral
conjunctival, papillary masses developed. The horse was euthanized. Nodular nasal and papillary conjunctival
masses consisting of rubbery, grey to yellow tissue were found at necropsy. At the limbus this tissue infiltrated and
expanded the cornea. The masses consisted of amyloid and moderate infiltrates of T lymphocytes and B lymphocytes
were present in the tissue. No predominance of either cell type was observed and no distinct neoplastic mass
could be identified. Ultrastructural examination of the nasal mucosa and cornea confirmed the presence of
abundant extracellular deposits of non-branching fibrils ranging from 9–11 nm in diameter consistent with
amyloid. Immunohistochemistry of amyloid revealed no labelling for AA amyloid, and no peptides representing
serum amyloid A (SAA) were detected by microscopic laser dissection and subsequent mass spectrometry.
Peptides from immunoglobulin kappa-like light chains were detected and are suggestive of AL amyloidosis,
however the results were inconclusive and a final identification of the amyloid protein could not be made.
Nasal amyloidosis is a clinical entity of localized amyloid deposits in the horse. Localized amyloidosis involving the
conjunctiva of the horse is previously described in only seven cases and the present case is the first case of
combined, localized nasal and corneal amyloidosis in the horse. In several reported cases surgical excision has
provided clinical improvement and return to normal levels of exercise, while medical treatment has had no effect.
The present case however, shows that rapid recurrence and progression of nasal amyloidosis to involve ocular
tissues can occur and lead to recurrent respiratory obstruction.
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Amyloidosis is a group of disorders characterized by
extracellular deposits of hyaline, proteinaceous material
which shows characteristic green birefringence under
polarized light after staining with Congo red. The different
amyloid proteins all form fibrils of beta pleated sheet
conformation that are resistant to degradation and
hence accumulate in tissues. Amyloid deposits are clas-
sified according to the type of protein deposited and as
localized or systemic based on tissue distribution [1].
Several forms of amyloidoses are reported in animals,* Correspondence: liv.ostevik@nmbu.no
1Department of Basic Sciences & Aquatic Medicine, Faculty of Veterinary
Medicine and Biosciences, Norwegian University of Life Sciences, N-0033
Oslo, Norway
Full list of author information is available at the end of the article
© 2014 Østevik et al., licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the or
Dedication waiver (http://creativecommons.or
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amyloidosis and amyloid A (AA) amyloidosis have been
described [1,2]. AA amyloidosis occur secondary to chronic
inflammatory conditions where AA protein, a modified
form of the acute phase protein, serum amyloid A (SAA), is
deposited in major organs. In the horse the AA amyloid
deposition preferentially occurs in the liver, but the spleen,
kidneys, adrenals, gastrointestinal tract and lymph nodes
may all be affected [2]. Both systemic and localized AL
amyloidosis may occur in horses [3-19]. Localized amyloid
deposition in horses primarily affects nasal tissue or skin,
and nasal AL amyloidosis is a clinical entity in the
horse [8-17]. Localized amyloidosis involving the con-
junctiva of the horse is previously described in seven cases
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Figure 1 Amyloid masses in the right rostral nasal cavity. Nodular
to diffuse thickening of the nasal mucosa at the mucocutaneous
junction were observed (arrows). The proliferative tissue was rubbery,
yellow to white and poorly demarcated from the surrounding
nasal mucosa.
Figure 2 Multiple papillary projections are present in the
conjunctiva. Irregular, papillary proliferations of the ocular
conjunctiva were evident.
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amyloidosis [12,16]. Equine corneal amyloid deposition is
reported only once, in a horse with initial nodular cutane-
ous amyloidosis [18]. To the best of our knowledge the
present case is the first equine case of combined, local-
ized nasal, conjunctival and corneal amyloidosis. The
purpose of this article is to describe the rare condition
of localized ocular and nasal amyloidosis in the horse
and provide a brief review of the literature.
Case presentation
A 15-year-old Norwegian Shetland pony mare was pre-
sented to an equine clinic with marked dyspnoea and
bilateral nodular and diffuse swelling of the nasal mucosa
at the mucocutaneous junction and rostral nasal concha
in June 2008. The nodular and diffuse swelling had been
present for at least two years and had gradually increased
in size and infiltrated the circumference of the nares to
cause markedly reduced luminal diameter of both nostrils.
Due to the respiratory difficulties surgical debulking of the
tissue was performed. Histological examination of the
excised tissue revealed large amounts of extracellular,
hyaline, eosinophilic, Congo red positive material in
the lamina propria of the nasal mucosa and a tentative
diagnosis of localized nasal amyloidosis was made. The
surgical treatment improved the clinical signs; however
the nodular swellings recurred over the next months
and multiple, papillary to nodular, conjunctival prolif-
erations also developed bilaterally. In March 2009 the
owners elected to euthanize the pony due to the recurrence
of the nodular swellings and a reduced general condition of
the animal as the swellings rapidly increased in size. The
pony was euthanized and immediately necropsied.
The mare was in normal body condition. A bilateral,
nodular to diffuse thickening of the nasal mucosa at the
mucocutaneous junction was evident (Figure 1). A nod-
ule measuring 2×1×1 cm was present in the right nostril,
as well as diffuse thickening of the rostral nasal mucosa.
Similar milder changes were observed in the left nostril.
There were bilateral, irregular, papillary proliferations in
the ocular conjunctiva (Figure 2) and intense conjunctival
hyperaemia. The proliferative tissue was rubbery, yellow
to white and was protruding above the eyelid margins
expanding the conjunctiva, causing marked disruption of
the normal contour of the eyelids. At the limbus the cor-
nea was expanded by a similar pale tissue. No other gross
abnormalities were noted. Tissue samples for histology
were collected from grossly abnormal tissue including the
ocular globe, conjunctivae, and nasal mucosa, as well as
sections from myocardium, lung, liver and kidney. Tissue
samples were fixed in 4% buffered formaldehyde, routinely
processed, embedded in paraffin, sectioned at 2 μm and
stained with haematoxylin and eosin. Sections from the
cornea, conjunctivae, nasal mucosa, liver and kidneywere also stained with Congo red according to Pucthler
et al. [20].
Immunohistochemistry was performed with the EnVi-
sion method using polyclonal rabbit anti-horse antibodies
specific for AA amyloid (Anti amyloid K-10a) in 1/100
dilution with phosphate buffered saline and bovine serum
albumin. Liver from a hyper-immunized horse used for
serum production with confirmed hepatic and systemic
amyloidosis served as positive control. Immunohisto-
chemistry to characterize the inflammatory infiltrate
was performed with polyclonal rabbit anti-human CD3
(A-0452, Dako, Glostrup, Denmark) and monoclonal
mouse anti-human CD79 αcy (M0755, Dako) antibodies.
Equine lymph node was used as positive control tissue.
For negative controls addition of the primary antibody
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toxylin, dehydrated, and mounted in polyvinyl alcohol
mounting medium.
For transmission electron microscopy selected areas of
paraffin embedded samples from the nasal mucosa and
cornea was deparaffinised with xylene, post-fixed with
2% osmium and re-embedded in LR-white. Counter-
staining was performed with 4% aqueous uranyl acetate
and 1% KMNO4.
Samples for mass spectrometry (MS) were collected
from formalin fixed paraffin embedded (FFPE) corneal
and nasal tissue by laser microdissection as described in
Additional file 1. Collection of only amyloid, identified as
Congo red positive extracellular material, was attempted.
Liver from the serum producing horse with systemic AA
amyloidosis served as positive control for AA amyloid
(data not shown). The collected material was subjected
to protein identification using MS and a FFPE antigen
retrieval approach [21]. MS raw files were submitted to
MaxQuant software version 1.4.0.5 [22] for peptide and
protein identification. Identification of peptides was based
on parent ion mass and unequivocal fragmentation
spectra.
Microscopic examination confirmed the presence of
multifocal to coalescing aggregates of a hyaline, eosinophilic
material in the lamina propria of the nasal mucocutaneous
junction, in the conjunctiva and in the corneal stroma
(Figure 3). Hyaline, eosinophilic material was observed
in the conjunctiva and nasal mucosa as large aggregates
expanding the lamina propria, in a narrow subepithelialFigure 3 Microscopic image of the conjunctiva. Multifocal to
coalescing aggregates of a hyaline, eosinophilic material were present
in the lamina propria of the conjunctiva (arrowheads). The papillary
structures consisted of lamina propria covered by hyperplastic, irregular
epithelium. Multifocal, mild to marked, subepithelial and perivascular
infiltrates of plasma cells and lymphocytes (arrows) occasionally
forming large nodular aggregates (*) were present in the lamina
propria. Haematoxylin and eosin stain; bar 100 μm.zone, in the interstitium of subepithelial glands of the
nasal mucosa and around vessels. Occasionally hyaline
deposits were present in the wall of arteries and arteri-
oles. Large aggregates of hyaline, eosinophilic material
were present in the superficial and middle aspect of the
limbal corneal stroma. Multifocally, mild infiltrates of
plasma cells, lymphocytes, macrophages, and occasional
clusters of multinucleated giant cells were observed in the
deposits in the cornea and conjunctiva. Macrophages and
giant cells seemed to phagocytise the hyaline material
(Figure 4). In the conjunctiva of the eyelids and the globe
papillary structures consisting of lamina propria covered
by hyperplastic, irregular epithelium was evident. Multi-
focal, moderate, subepithelial and perivascular infiltrates
of plasma cells and lymphocytes occasionally forming
nodular aggregates were present in the lamina propria of
the nasal mucosa and conjunctiva. Mild subepithelial infil-
tration of plasma cells and lymphocytes was present in the
limbal cornea. Additional findings in the conjunctiva in-
cluded mild, multifocal infiltrates of partially degenerate
neutrophilic granulocytes, intraepithelial pustules and
neutrophil exocytosis.
The hyaline, eosinophilic material in both the nasal tissue,
conjunctiva and cornea stained strongly with Congo red
and displayed apple green birefringence in polarized light
consistent with amyloid (Figure 5). No significant lesions or
homogenous, eosinophilic, extracellular material suggestive
of amyloid were detected in other examined organs and no
Congo red positive material was observed when examining
liver and kidney sections in polarized light.
The amyloid in the nasal mucosa and cornea was nega-
tive for anti-AA amyloid antibodies. The lymphocytesFigure 4 Amyloid deposits and inflammatory infiltrates in the
cornea. Multifocal clusters of multinucleated giant cells (arrows),
macrophages, lymphocytes and plasma cells surrounded the
deposits in the cornea (*). Macrophages and giant cells appeared to
have phagocytised amyloid (arrowheads). Corneal neovascularisation
was also evident. Haematoxylin and eosin stain; bar 20 μm.
Figure 6 Transmission electron microscopy the cornea revealed
abundant amyloid deposits. Surrounding a corneal blood vessel
(arrow) was perivascular, extracellular non-branching fibrils (*). The
fibrils ranged from 9–11 nm in diameter consistent with amyloid.
Inset shows fibrils at high magnification. Bar 5 μm, inset; bar 500 nm.
Figure 5 Nasal amyloid display apple green birefringence in
polarized light. Multifocal to coalescing aggregates of hyaline,
eosinophilic material in the lamina propria of the nasal
mucocutaneous junction were observed perivascularly (arrow)
and in a narrow subepithelial zone (arrowheads). The hyaline,
eosinophilic material stained positive with Congo red and
displayed apple green birefringence in polarized light. The
collagen fibres of the lamina propria show white birefringence.
Congo red stain; bar 100 μm.
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of a mix of CD3+ T cells and CD79+ B cells. No clear
predominance of either cell population was observed.
Ultrastructural studies of both the nasal mucosa and
cornea confirmed the presence of abundant extracellu-
lar deposits of straight non-branched fibrils ranging
from 9–11 nm in diameter consistent with amyloid
(Figure 6) [1].
Mass spectrometry data did not show a clear identifi-
cation of the amyloid protein in any of the samples. Sev-
eral immunoglobulin kappa-like peptides were detected
among the most abundant proteins, but also albumin
and hemoglobin were high on the list, indicating serum
contamination of the sample (Additional file 2: Table S1
and Additional file 3: Table S2). Proteins from two other
known amyloid precursor proteins, apolipoprotein A1 and
apolipoprotein A4, were among the fifteen most abundant
proteins identified in nasal and corneal samples. We also
detected low amounts of peptides of other known amyloid
precursor proteins, including lambda-like light chains,
gelsolin, lysozyme and fibrinogen.
Conclusions
The histological and immunohistochemical findings in
this case are highly suggestive of localized, nasal and
ocular, amyloid light chain amyloidosis. The lack of im-
munoreactivity to AA amyloid antibodies and the fact
that no SAA peptides were detected by mass spectrom-
etry suggests that a SAA protein origin is very unlikely.
Lambda chains predominate in normal horse serum [23]with a reported kappa lambda ratio of approximately 0.08
[24,25]. The kappa abundance in samples analyzed by MS
indicates overrepresentation of kappa light chains in
the specimen, indicating a diagnosis of localized light
amyloidosis of kappa type, alternatively a monoclonal
gammopathy of kappa type with serum contamination
of the specimens. Unfortunately, no serum samples
were analyzed to exploit this further. At present only
AA and AL amyloidosis have been described in the horse,
however, with 30 different amyloid proteins identified in
man [1], the possibility of a non-AA and non-AL amyloid-
osis in the horse should also be considered.
Localized, nasal amyloidosis is a rare clinical entity in
the horse with only 23 reported cases (Table 1). Equine
idiopathic, localized, nasal amyloidosis also involving the
conjunctiva is rare, and amyloid deposition in the cornea
in this entity has not been described previously. A horse
described by Geisel et al. [18] developed unilateral corneal
and conjunctival amyloidosis after initial presentation
with nodular cutaneous amyloidosis. Over a period of
8 months after initial diagnosis this horse developed
extensive, multifocal amyloid deposits involving not
only skin, but also muscle, subcutaneous fat, nasal mu-
cosa, the joint capsule and tendon of the tarsal joint,
and was diagnosed with extramedullary plasmacytoma
[18]. In both our case and the case described by Geisel
et al. [18] amyloid deposition most likely affected the
ocular structures by extension and progression of the
amyloid disease.
Table 1 Reported equine cases of localized nasal and ocular amyloidosis
Year Authors No
cases
Type of
amyloid
Method of
amyloid typing
Locations Location Clinical signs Concurrent diagnosis Treatment (T)
Eye Nose Other Outcome (O)
1942 Hjarre and
Nordlund [12]
3 Unknown ND 1 3 3 1 case larynx,
guttural pouches,
pharynx, trachea,
lungs (bronchii),
submaxillary,
retropharyngeal,
mesenterial and
thoracic lymph
nodes, conjunctiva
1 case larynx and
local lymph nodes
1 case larynx
Dyspnoea and
epistaxis
Case 1: Acute purulent
bronchopneumonia
Euthanasia
1927 to
70
Saunders and
Rubin [19]
3 Unknown NR 3 Conjunctiva NR NR NR
1987 Shaw et al. [8] 4 Unknown.
Presumed AA
PS 4 1 1 case pharynx Dyspnoea, reduced
performance,
respiratory stertor
T: Topical and systemic
cortisone - no effect,
then surgical excision,
O: Returned to former
use, no recurrence for
1 year
1988 Nappert et al. [11] 2 Unknown.
Presumed AL
PS 2 Dyspnoea, epistaxis T: Topical cortisone,
O: No effect - euthanasia -
one case. One case: NR
1988 Van Andel et al.,
Niewold et al.#
[14,17]
6 AL PS, IHC* Case
1WB AAS WB,
AAS
6 1 Case 1- nodules
subcutaneously,
within fasciae and
muscle, superficial
lymph nodes,
oesophagus, synovium,
ileocaceal valve, thoracic
cavity
Dyspnoea, stertor,
epistaxis, wasting
Case 1: Histolymphocytic
lymphosarcoma
T: Case 1; none,
O: Euthanasia, Case 1,
Case 2–6: NR
1989 Linke and
Trautwein [13]
2 AL IHC 2 Dyspnoea T: Surgical excision
O: NR
1990 Mould et al. [16] 1 AL WB, PS 1 1 Epistaxis and blood
tinged epiphora
T: Surgical excision,
O: Clinical relief, no
recurrence 9 month
follow-up
1994 Kasper et al. [10] 2 Unknown,
Presumed AL
(1) AA (1)
PS 2 Dyspnoea, nasal discharge,
respiratory stertor, episodic
epistaxis
T: 1 case surgical excision,
1 case N,
O: Improvement of clinical
symptoms, no recurrence
12 month follow up
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Table 1 Reported equine cases of localized nasal and ocular amyloidosis (Continued)
2012 Portela et al. [9] 1 Unknown ND 1 Epistaxis T: Surgical excision,
O: Stable, but not in
training
2012 Axiak and
Johnson [15]
1 Unknown ND 2 Exercise intolerance NR T: 1 case surgical excision,
1 case NR,
O: Improvement of clinical
symptoms, unknown
follow-up
2014 Østevik et al.
(this publication)
1 Unknown,
Presumed AL
IHC* 1 1 Dyspnoea, epiphora,
conjunctivitis
Gastrophilus sp.
infestation of
gastric mucosa
T: Surgical excision,
O: Recurrence amyloid
and extension to cornea
and conjunctiva -
euthanasia
Cases of localized ocular and combined nasal and ocular (conjunctival) amyloidosis are in bold. Cases of ERU, in which the hallmark lesion is ciliary body amyloid deposits, are not included. PS - Potassium permanganate sensitivity,
IHC - immunohistochemistry for AL amyloid, IHC*- immunohistochemistry for amyloid A amyloid, WB - western blot, ND - not done, AAS - amino acid sequencing, NR - not reported. #Amyloid from case 1 in the paper by van Andel
et al. [14] is further characterized by Niewold et al. [17] and this case is therefore not included as separate case in this table.
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conjunctival amyloidosis has been reported in the litera-
ture. In this case the amyloid deposits were believed to be
secondary to previous ocular trauma; however neither the
corneal or conjunctival amyloid deposits were subjected
to any form of typing [26]. Localized conjunctival AL
amyloidosis is a rare condition in humans, and appears to
be an entity distinct from localized nasopharyngeal and
laryngo-tracheobronchial amyloidosis [27-29]. Ocular
amyloidosis limited to the cornea secondary to chronic
inflammation, such as trichiasis and keratoconus, are
rare conditions in humans, and the precursor protein
in these cases are lactoferrin produced by the corneal
epithelium [30]. Additionally localized corneal amyloid
deposition occurs in human gelatinous drop dystrophy
and lattice dystrophies [1]. In these cases the amyloid pre-
cursor protein is lactoferrin in gelatinous drop dystrophy
and kerato-epithelin or gelsolin in lattice dystrophies [1].
Immunohistochemistry and mass spectrometry are used
to type amyloid in human medicine, and equine amyloid
light chain deposits have been shown to cross-react with
some anti-human light chain antibodies, however not con-
sistently [5,13]. Typing of AL amyloid by immunohisto-
chemistry is very challenging also in man. False negative
results when using commercial light chain antibodies
which frequently recognize epitopes on the constant
portion of the light chain [31] is a major problem.
There is a vast variability from case to case in light
chain proteins which are highly modified. Additionally
some authors report damage to AL deposits by formalin
fixation [32], nonspecific antibody absorption of anti-
bodies may occur due to amyloid “stickiness” [33] and the
formalin fixation process can trap abundant normal serum
protein in the tissue and amyloid deposits, leading to non-
specific background positivity, (“contamination”) [31,33].
Contamination can also be a problem in MS, causing
identification of irrelevant “background" proteins as seen
in our case. Lastly, in very rare cases, co-deposition of
more than one amyloid protein has been reported [34].
Clinical signs in this case consisted of dyspnoea and
epiphora and are most likely related to the space-occupying
effect of the nodular amyloid deposits. In other cases of
conjunctival and nasal amyloidosis epistaxis, blood tinged
tears, respiratory stertor, nasal obstruction and exercise in-
tolerance have been reported [8,11,12,14,16]. The masses
of amyloid lead to nasal obstruction, with abnormal and
reduced airflow causing both stertor and reduced exercise
tolerance. Bleeding is believed to be a consequence of
increased fragility of the mucosa in the affected areas lead-
ing to erosions and ulcerations, as well as loss of vascular
integrity due to amyloid infiltrating blood vessels [35].
Conjunctivitis was observed in both our case and the case
described by Geisel et al. [18] and may be secondary to
physical disruption of the normal eyelid function by theextensive amyloid deposits. The amyloid fibrils are reported
to have toxic properties, however ocular amyloidosis in
humans is generally not associated with inflammation
or pain and this is unlikely to be the cause of the
conjunctivitis.
Primary localized conjunctival, as well as localized naso-
pharyngeal and laryngo-tracheobronchial AL amyloidosis
has been described in humans [27-29,36]. Amyloid depos-
ition may be non-progressive or progressive, and symptom-
atic surgical debulking is the treatment of choice and will
often be successful in relieving the clinical signs [27,28,36].
The condition is considered benign and prognosis for
survival is good to excellent, however the condition is
often incurable and recurrence of amyloid deposits is
noted in up to 50% of patients after surgical resection of
the affected tissue [27,36]. Progression to systemic amyl-
oidosis develops extremely rarely, but deaths due to severe
haemorrhage of affected airways, as well as respiratory
failure and recurrent airway obstruction have been re-
ported in human patients with amyloidosis of the respira-
tory tract [27,37-39].
Surgical debulking of the affected nasal mucosa was
performed and initially provided clinical relief in the
pony mare. Recurrence occurred relatively rapidly and
amyloid deposits also developed in the conjunctivae and
cornea prompting the owners to euthanize the horse.
This contrasts with previous results as surgical treatment
in eight equine cases improved the clinical signs and
horses successfully returned to previous levels of per-
formance [8-10,15,16]. No recurrence or increase in
the remaining amyloid deposits were observed, how-
ever follow up time was limited to 12 months in all cases.
Additionally, these cases may not be representative be-
cause in many of the equine cases (10/23) outcome was
not reported [10,11,13-15] and five horses were eutha-
nized without treatment or after unsuccessful medical
treatment [11,12,14].
Progression to systemic AL amyloidosis has not been
reported in the horse, however the localized nasal amyl-
oidosis in horses seems to be less strictly limited to the
respiratory tract, compared to people, where nasal and
conjunctival amyloidosis are distinct entities [27,28].
One horse initially presented with nasal amyloid de-
posits, subsequently developed T-cell rich B-cell lymph-
oma (histiolymphocytic lymphosarcoma) and amyloid
deposition in multiple tissues, but parenchymal organs
remained unaffected [14]. Additionally, nasal amyloid-
osis in horses can progress to involve the ocular struc-
tures [12] and progression of conjunctival amyloid to
involve the nasal mucosa has been reported in a single
horse [16]. Three equine cases with sole affection of
conjunctival tissues are also described, however no in-
formation regarding development of the condition and
outcome are reported [19].
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Additional files
Additional file 1: Mass spectrometry method.
Additional file 2: Table S1. Top 15 most abundant proteins from the
cornea as identified by mass spectrometry. Immunoglobulin kappa-like
proteins, apoplipoprotein A1 (APOA1) and apolipoprotein A4 (APOA4) are
among the most abundant proteins identified in the sample. However,
high amounts of hemoglobin indicative of serum contamination was also
detected.
Additional file 3: Table S2. Top 15 most abundant proteins from nasal
mucosa as identified by mass spectrometry. Immunoglobulin kappa-like
proteins and apoplipoprotein A1 (APOA1) are among the most abundant
proteins identified in the sample. However, high amounts of hemoglobin
and albumin indicative of serum contamination was also detected.
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